- Pages
- 38
- Published in
- United States of America
How We Use Genomics and BTK-Inhibitors in the Treatment of Waldenstrom Macroglobulinemia.
2024
<Macro 'access_denied_modal'>
<Macro 'unauthorized_modal'>
Add to list
Citation
IWMF, 2024. How We Use Genomics and BTK-Inhibitors in the Treatment of Waldenstrom Macroglobulinemia., IWMF: International Waldenstrom's Macroglobulinemia Foundation.
United States of America.
Retrieved from https://coilink.org/20.500.12592/4p0cokk on 15 Nov 2024. COI: 20.500.12592/4p0cokk.
Full-page Screenshot
